In breast carcinoma cells, metformin treatment modulated the expression and function of tumor suppressor p53 and reduced the levels of cyclin-D1 thereby causing cell cycle arrest and inhibiting tumor cell growth [142,143]. Here, TP53 is linked to neoplasm.